N-{6-[2-(2-Dimethylamino-phenylmethanesulfinyl)-imidazol-1-yl]-pyridin-3-yl}-acetamide

ID: ALA155083

PubChem CID: 10833852

Max Phase: Preclinical

Molecular Formula: C19H21N5O2S

Molecular Weight: 383.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1ccc(-n2ccnc2[S+]([O-])Cc2ccccc2N(C)C)nc1

Standard InChI:  InChI=1S/C19H21N5O2S/c1-14(25)22-16-8-9-18(21-12-16)24-11-10-20-19(24)27(26)13-15-6-4-5-7-17(15)23(2)3/h4-12H,13H2,1-3H3,(H,22,25)

Standard InChI Key:  ZNNNROZVKDIUCN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    5.8904   -3.0523    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1325   -3.3968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4162   -2.9846    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.0516   -2.2485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2352   -4.2220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7091   -4.2349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4407   -1.6958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7010   -3.4013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5128   -3.6024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9939   -4.6516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0390   -4.3832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9206    0.7328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4129   -2.1590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5429    0.1827    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2776   -4.2394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8350   -1.9798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1372    0.4642    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6019   -0.8920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3772   -0.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0007   -1.1691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4334   -4.6424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0007   -5.4795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0818    1.5366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5624   -4.6562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2673   -3.4093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4367   -5.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7215   -5.8848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  1  1  0
  5  2  2  0
  6  8  1  0
  7  4  2  0
  8  3  1  0
  9  1  1  0
 10  6  1  0
 11  9  2  0
 12 14  1  0
 13  3  1  0
 14 19  1  0
 15 10  1  0
 16  4  1  0
 17 12  2  0
 18  7  1  0
 19 20  1  0
 20 16  2  0
 21  6  2  0
 22 10  2  0
 23 12  1  0
 24 15  1  0
 25 15  1  0
 26 21  1  0
 27 26  2  0
  5 11  1  0
 19 18  2  0
 27 22  1  0
M  CHG  2   3   1  13  -1
M  END

Associated Targets(non-human)

ATP4B Potassium-transporting ATPase (475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Atp4a Potassium-transporting ATPase (425 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.48Molecular Weight (Monoisotopic): 383.1416AlogP: 2.60#Rotatable Bonds: 6
Polar Surface Area: 86.11Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.59CX LogP: 1.75CX LogD: 1.75
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -1.61

References

1. Yamada M, Yura T, Morimoto M, Harada T, Yamada K, Honma Y, Kinoshita M, Sugiura M..  (1996)  2-[(2-Aminobenzyl)sulfinyl]-1-(2-pyridyl)-1,4,5,6-tetrahydrocyclopent[d]imidazoles as a novel class of gastric H+/K+-ATPase inhibitors.,  39  (2): [PMID:8558532] [10.1021/jm950610n]

Source